AbbVie Inc.
ABBV
$210.75
-$0.79-0.37%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.28B | 5.12B | 5.34B | 5.99B | 4.86B |
| Total Depreciation and Amortization | 8.39B | 8.36B | 8.52B | 8.65B | 8.70B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.92B | 4.97B | 4.85B | 4.18B | 6.47B |
| Change in Net Operating Assets | -2.78B | -1.94B | -65.00M | 3.87B | 2.81B |
| Cash from Operations | 18.81B | 16.51B | 18.64B | 22.69B | 22.84B |
| Capital Expenditure | -974.00M | -888.00M | -858.00M | -795.00M | -777.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -20.52B | -19.28B | -10.94B | -10.26B | -1.22B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 671.00M | 420.00M | -59.00M | -44.00M | -9.00M |
| Cash from Investing | -20.82B | -19.75B | -11.86B | -11.10B | -2.01B |
| Total Debt Issued | 21.97B | 19.97B | 19.97B | 19.97B | -- |
| Total Debt Repaid | -14.62B | -10.65B | -10.25B | -7.91B | -4.15B |
| Issuance of Common Stock | 214.00M | 235.00M | 204.00M | 242.00M | 180.00M |
| Repurchase of Common Stock | -1.71B | -1.35B | -1.34B | -1.34B | -1.97B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.03B | -10.90B | -10.78B | -10.65B | -10.54B |
| Other Financing Activities | -42.00M | -100.00M | -196.00M | -527.00M | -742.00M |
| Cash from Financing | -5.21B | -2.80B | -2.39B | -211.00M | -17.22B |
| Foreign Exchange rate Adjustments | -65.00M | 4.00M | -20.00M | -21.00M | 5.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.29B | -6.03B | 4.37B | 11.36B | 3.61B |
